These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7420114)

  • 1. Effect of age on the detection rate in Duchenne muscular dystrophy.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):407-10. PubMed ID: 7420114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA; Dubowitz V
    J Neurol Sci; 1981 Feb; 49(2):305-24. PubMed ID: 6452514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Duchenne muscular dystrophy carriers: quantitative echography and creatine kinasemia.
    Schapira G; Laugier P; Rochette J; Berger G; Katz P; Perrin J
    Hum Genet; 1987 Jan; 75(1):19-23. PubMed ID: 3542803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience].
    Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM
    J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum creatine kinase estimation with short tandem repeats based linkage analysis in carriers and affected children of Duchenne muscular dystrophy.
    Hashim R; Shaheen S; Ahmad S; Sattar A; Khan FA
    J Ayub Med Coll Abbottabad; 2011; 23(1):125-8. PubMed ID: 22830166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of young female carriers of Duchenne muscular dystrophy].
    Alvarez Leal MA; Morales-Aguilera A
    Arch Invest Med (Mex); 1990; 21(3):269-72. PubMed ID: 2131776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 18. Carrier detection in Becker muscular dystrophy using creatine kinase estimation and DNA analysis.
    Kingston HM; Sarfarazi M; Newcombe RG; Willis N; Harper PS
    Clin Genet; 1985 Apr; 27(4):383-91. PubMed ID: 3995787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoglobinemia in Duchenne muscular dystrophy carriers.
    Ando T; Kato T; Ohsawa M; Fukuyama Y
    Brain Dev; 1980; 2(1):87-8. PubMed ID: 7416442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum myoglobin in muscular dystrophy and carrier detection.
    Nicholson LV
    J Neurol Sci; 1981 Sep; 51(3):411-26. PubMed ID: 7276986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.